155 related articles for article (PubMed ID: 8819078)
61. Fluorescent in situ hybridization analysis of Philadelphia chromosome-negative chronic myeloid leukemia with the bcr/abl fusion gene.
Monma F; Nishii K; Yamamori S; Hosokai N; Nakazaki T; Lorenzo F; Usui E; Sakakura M; Miyashita H; Fujieda A; Ohishi K; Katayama N; Shiku H
Int J Hematol; 2004 Aug; 80(2):155-8. PubMed ID: 15481444
[TBL] [Abstract][Full Text] [Related]
62. Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid leukemia.
Landstrom AP; Ketterling RP; Knudson RA; Tefferi A
Leuk Lymphoma; 2006 Oct; 47(10):2055-61. PubMed ID: 17071476
[TBL] [Abstract][Full Text] [Related]
63. [Monitoring of bcr/abl fusion gene by interphase-dual-color and dual-fusion fluorescence in situ hybridization in CML after allo-HSCT].
Qian SX; Li JY; Zhang R; Hong M; Qiu HR; Li L; Xu W; Sheng RL; Wu HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):577-81. PubMed ID: 16800946
[TBL] [Abstract][Full Text] [Related]
64. [Study of deletion of derivative chromosome 9 in patients with Ph+ chronic myeloid leukemia].
Wu W; Xue YQ; Wu YF; Pan JL; Shen J
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):183-6. PubMed ID: 16792921
[TBL] [Abstract][Full Text] [Related]
65. Fluorescence in situ hybridization studies of interphase nuclei for assessing response to therapy in patients with chronic myeloid leukemia.
Kobzev Y; Domracheva E; Zakharova A; Khoroshko N; Turkina A; Dewald G
Cancer Genet Cytogenet; 1998 Oct; 106(2):128-34. PubMed ID: 9797777
[TBL] [Abstract][Full Text] [Related]
66. Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.
Gargallo P; Cacchione R; Chena C; Dupont J; Garay G; Riveros D; Larripa I; Slavutsky I
Cancer Genet Cytogenet; 2005 Aug; 161(1):74-7. PubMed ID: 16080961
[TBL] [Abstract][Full Text] [Related]
67. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
Al-Achkar W; Wafa A; Nweder MS
J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
[TBL] [Abstract][Full Text] [Related]
68. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
[TBL] [Abstract][Full Text] [Related]
69. The incidence and patterns of BCR/ABL rearrangements in chronic myeloid leukaemia (CML) using fluorescence in situ hybridisation (FISH).
Lim TH; Tien SL; Lim P; Lim AS
Ann Acad Med Singap; 2005 Oct; 34(9):533-8. PubMed ID: 16284673
[TBL] [Abstract][Full Text] [Related]
70. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.
Nishigaki H; Misawa S; Inazawa J; Abe T
Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904
[TBL] [Abstract][Full Text] [Related]
71. Extensive cytogenetic studies of clonality following interferon-alpha therapy in chronic myeloid leukemia occurring in monosomic cells in a patient with Turner syndrome mosaic.
Takeshita A; Shinjo K; Yamashita M; Fujisawa S; Naito K; Ohnishi K; Takahashi K; Matsui H; Ohno R
Leukemia; 1999 Nov; 13(11):1749-53. PubMed ID: 10557048
[TBL] [Abstract][Full Text] [Related]
72. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of minimal residual disease in patients with chronic myeloid leukaemia on IFN-alpha 2b therapy using conventional cytogenetics and fluorescence in situ hybridization.
Talwar R; Choudhry VP; Jobanputra V; Kucheria K
Natl Med J India; 2002; 15(4):195-8. PubMed ID: 12296472
[TBL] [Abstract][Full Text] [Related]
74. A complex chromosome rearrangement forms the BCR-ABL fusion gene in leukemic cells with a normal karyotype.
Morris C; Kennedy M; Heisterkamp N; Columbano-Green L; Romeril K; Groffen J; Fitzgerald P
Genes Chromosomes Cancer; 1991 Jul; 3(4):263-71. PubMed ID: 1958592
[TBL] [Abstract][Full Text] [Related]
75. Trisomy 8 detection in Ph+ CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques.
Fugazza G; Bruzzone R; Dejana AM; Patrone F; Sessarego M
Cancer Genet Cytogenet; 1994 Jan; 72(1):24-7. PubMed ID: 8111734
[TBL] [Abstract][Full Text] [Related]
76. Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization.
Amiel A; Yarkoni S; Slavin S; Or R; Lorberboum-Galski H; Fejgin M; Nagler A
Cancer Genet Cytogenet; 1994 Aug; 76(1):59-64. PubMed ID: 8076354
[TBL] [Abstract][Full Text] [Related]
77. Fluorescence in situ hybridization for the BCR/ABL rearrangement is dependent on the percentage of nonlymphocytic cells in peripheral blood stem cell harvests.
Bornhäuser M; Mohr B; Ehrenlechner U; Neubauer A; Ehninger G
J Hematother; 1998 Oct; 7(5):425-30. PubMed ID: 9829316
[TBL] [Abstract][Full Text] [Related]
78. Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment.
Seong DC; Kantarjian HM; Ro JY; Talpaz M; Xu J; Robinson JR; Deisseroth AB; Champlin RE; Siciliano MJ
Blood; 1995 Sep; 86(6):2343-9. PubMed ID: 7662980
[TBL] [Abstract][Full Text] [Related]
79. Fluorescence in situ hybridization analysis of complex translocations in two newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia patients.
Rajcan-Separovic E; Bence-Bruckler I; Wells P; Wang H
Cancer Genet Cytogenet; 1999 Oct; 114(1):71-4. PubMed ID: 10526539
[TBL] [Abstract][Full Text] [Related]
80. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique Hématologique.
Martiat P; Michaux JL; Rodhain J
Blood; 1991 Jul; 78(1):205-11. PubMed ID: 2070054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
